Comparative Pharmacology
Head-to-head clinical analysis: LIPOSYN 10 versus LIPOSYN III 30.
Peer-Reviewed Evidence
Head-to-head clinical analysis: LIPOSYN 10 versus LIPOSYN III 30.
LIPOSYN 10% vs LIPOSYN III 30%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Intravenous fat emulsion provides a source of calories and essential fatty acids as a component of parenteral nutrition. The lipid particles are metabolized similarly to endogenous chylomicrons, undergoing hydrolysis by lipoprotein lipase to release free fatty acids, which are then used for energy or stored.
Liposyn III 30% is a lipid emulsion providing essential fatty acids (linoleic and linolenic acids) and calories for parenteral nutrition. It serves as a substrate for energy production and component of cell membranes.
Intravenous infusion: 1-2 g/kg/day (10-20 mL/kg/day) as part of parenteral nutrition, not to exceed 2.5 g/kg/day. Infusion rate: initially 0.5-1 mL/min for 30 minutes, then increase to maximum 125 mL/hour if tolerated.
Adults: 1-2 g/kg/day intravenously, not to exceed 2.5 g/kg/day. Initial rate 0.5-1 mL/min for first 30 minutes, increase to 100-125 mL/h as tolerated.
None Documented
None Documented
Lipid emulsion particles: elimination half-life of 10-15 minutes; triglycerides: terminal half-life of 1-3 hours, reflecting redistribution and clearance from adipose tissue; clinical context: half-life is dose-dependent and prolonged in hypertriglyceridemia, hepatic impairment, or sepsis.
The terminal elimination half-life of the triglyceride component is approximately 30 minutes (range 20-40 minutes) in patients with normal lipid metabolism. In critically ill patients or those with impaired clearance, half-life may be prolonged.
Renal: negligible; biliary: negligible; fecal: negligible; eliminated via peripheral lipoprotein lipase-mediated hydrolysis and subsequent metabolism of fatty acids, with CO2 production (~50-60%) and recycling into triglycerides and phospholipids; complete clearance from plasma within 24 hours of infusion cessation.
Liposyn III 30% is a fat emulsion; its components are metabolized like endogenous triglycerides. Clearance involves hydrolysis by lipoprotein lipase, releasing free fatty acids which are oxidized or stored. Less than 1% is excreted unchanged in urine; a small fraction is excreted in bile/feces. No significant renal or biliary elimination of intact emulsion.
Category C
Category C
Intravenous Fat Emulsion
Intravenous Fat Emulsion